William Robert Elder

CIK: 0001828068

Transaction Breakdown

Open Market Buys (P)4 (66.7%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CRVO

CervoMed Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

CRVO
CervoMed Inc.
Feb 11, 2026
Award(A)
Stock Option (Right to Buy)
Direct
30K shares-
CRVO
CervoMed Inc.
Nov 18, 2025
Purchase(P)
Direct
2.5K shares at avg. $8.32$21K
CRVO
CervoMed Inc.
Nov 17, 2025
Purchase(P)
Direct
1K shares at avg. $8.45$8K
CRVO
CervoMed Inc.
Nov 12, 2025
Purchase(P)
Direct
3.5K shares at avg. $7.44$26K
CRVO
CervoMed Inc.
May 14, 2025
Purchase(P)
Direct
4.2K shares at avg. $8.46$36K
CRVO
CervoMed Inc.
Feb 4, 2025
Award(A)
Stock Option (Right to Buy)
Direct
27K shares-

		Type	Shares	Price		Ownership
Feb 11, 2026	CRVO CervoMed Inc.	Award(A) Stock Option (Right to Buy)	30,000	-	-	Direct
Nov 18, 2025	CRVO CervoMed Inc.	Purchase(P)	2,500	$8.32	$20,800	Direct
Nov 17, 2025	CRVO CervoMed Inc.	Purchase(P)	1,000	$8.45	$8,450	Direct
Nov 12, 2025	CRVO CervoMed Inc.	Purchase(P)	3,500	$7.44	$26,040	Direct
May 14, 2025	CRVO CervoMed Inc.	Purchase(P)	4,233	$8.46	$35,811	Direct
Feb 4, 2025	CRVO CervoMed Inc.	Award(A) Stock Option (Right to Buy)	27,000	-	-	Direct

1-6 of 6 transactions

About ELDER WILLIAM ROBERT

ELDER WILLIAM ROBERT (SEC CIK 0001828068) files insider reports with the SEC as CFO, GC & Secretary of CervoMed Inc. (CRVO).

Signal8 holds 5 ownership filings by ELDER WILLIAM ROBERT, all Form 4s, filed between Feb 14, 2025 and Feb 13, 2026. Those filings report 6 transactions, from Feb 4, 2025 to Feb 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on ELDER WILLIAM ROBERT's filings is in BOSTON, MA.

Recent filings by ELDER WILLIAM ROBERT

Feb 11, 2026: Grant or award of CRVO derivative securities (Form 4, code A).
Nov 18, 2025: Open-market purchase of CRVO shares (Form 4, code P).
Nov 17, 2025: Open-market purchase of CRVO shares (Form 4, code P).
Nov 12, 2025: Open-market purchase of CRVO shares (Form 4, code P).
May 14, 2025: Open-market purchase of CRVO shares (Form 4, code P).

Other insiders filing for CervoMed Inc. (CRVO)

Blackburn Kelly, EVP, Clinical Development
De Rosch Mark, EVP, RA and GA and PgM
Winton Matthew, Chief Commercial and Business
BOGER JOSHUA S, Director
ZAVRL FRANK, Director
Sabbagh Marwan, Director

How to read Form 4 transaction codes